Table 1 Demographics and screening results for control and intervention patients according to place of screening
Vaccination and Infection Control Office (VICO) | Refugee Healthcare Centre (RHC) | ||||
|---|---|---|---|---|---|
Period of registration | Control period Sept 2009-Aug 2010 (No 134) | Intervention period July 2011-June 2012 (No 123) | Control period Oct 2010-April 2011 (No 46) | Intervention period Sept 2011-June 2012 (No 59) | |
Age | Median (range) | 30 (16–74) | 29 (19–77) | 28,5 (17–59) | 27 (16–71) |
Gender | Female 95% CI | 82 (61%) 53-69 | 86 (70%) 62-78 | 19 (41%) 27-56 | 29 (49%) 36-62 |
Mantoux test | >15 mm 95% CI | 97 (72%) 65-80 | 105 (85%) 79-92 | 27 (59%) 44-73 | 36 (61%) 49-73 |
QuantiFERON | Positiv 95% CI | 89 (66%) 58-74 | 74 (60%) 52-69 | 37 (80%) 69-92 | 42 (71%) 60-83 |
Negativ 95% CI | 41 (31%) 23-38 | 39 (32%) 23-40 | 8 (17%) 6-28 | 10 (17%) 7-27 | |
Chest X-ray | Abnormal 95% CI | 19 (14%) 8-20 | 28 (23%) 15-30 | 1 (2%) −2-6 | 9 (15%) 6-24 |
Diagnose | TB disease 95% CI | 0 | 1 (1%) 0-2 | 1 (2%) 0-6 | 2 (3%) 0-8 |
Latent TB 95% CI | 44 (33%) 25-41 | 62 (50%) 42-59 | 28 (61%) 47-75 | 40 (68%) 56-80 | |
Previous TB 95% CI | 4 (3%) 0-6 | 10 (8%) 3-13 | 0 | 6 (10%) 2-18 | |
Treatment for latent TB | Yes 95% CI | 19 (14%) 8-20 | 21 (17%) 10-24 | 16 (35%) 21-49 | 31 (53%) 40-65 |
No 95% CI | 90 (67%) 59-75 | 91 (73%) 66-82 | 7 (15%) 5-26 | 19 (32%) 20-44 | |